Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1LU7W
|
|||
| Drug Name |
NP001
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Phase 2 | [1] | |
| Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [2] | ||
| Company |
Neuraltus Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01281631) A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.